161 related articles for article (PubMed ID: 10622069)
1. 123I-metaiodobenzylguanidine scans in phaeochromocytoma diagnosis: current clinical practice and relationship to biochemical screening.
Tormey WP; Keeling F; Lee MJ
Int J Clin Pract; 1999 Sep; 53(6):428-32. PubMed ID: 10622069
[TBL] [Abstract][Full Text] [Related]
2. 123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation.
Bhatia KS; Ismail MM; Sahdev A; Rockall AG; Hogarth K; Canizales A; Avril N; Monson JP; Grossman AB; Reznek RH
Clin Endocrinol (Oxf); 2008 Aug; 69(2):181-8. PubMed ID: 18394016
[TBL] [Abstract][Full Text] [Related]
3. Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma?
Taïeb D; Sebag F; Hubbard JG; Mundler O; Henry JF; Conte-Devolx B
Clin Endocrinol (Oxf); 2004 Jul; 61(1):102-8. PubMed ID: 15212651
[TBL] [Abstract][Full Text] [Related]
4. Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas--experience and meta-analysis.
Van Der Horst-Schrivers AN; Jager PL; Boezen HM; Schouten JP; Kema IP; Links TP
Anticancer Res; 2006; 26(2B):1599-604. PubMed ID: 16619578
[TBL] [Abstract][Full Text] [Related]
5. [Nuclear medicine diagnosis of pheochromocytoma with metaiodobenzylguanidine].
Pucar D; Marković S
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():20-4. PubMed ID: 12584993
[TBL] [Abstract][Full Text] [Related]
6. Meta-iodobenzylguanidine (MIBG) scanning in the diagnosis of phaeochromocytoma.
Clesham CJ; Kennedy A; Lavender JP; Dollery CT; Wilkins MR
J Hum Hypertens; 1993 Aug; 7(4):353-6. PubMed ID: 8410925
[TBL] [Abstract][Full Text] [Related]
7. Intraindividual comparison of 123I-mIBG SPECT/MRI, 123I-mIBG SPECT/CT, and MRI for the detection of adrenal pheochromocytoma in patients with elevated urine or plasma catecholamines.
Derlin T; Busch JD; Wisotzki C; Schoennagel BP; Bannas P; Papp L; Klutmann S; Habermann CR
Clin Nucl Med; 2013 Jan; 38(1):e1-6. PubMed ID: 22996238
[TBL] [Abstract][Full Text] [Related]
8. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP
J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618
[TBL] [Abstract][Full Text] [Related]
9. A diagnostic dilemma in diagnosing and managing an incidental phaeochromocytoma.
Tahrani AA; Macleod AF
Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):204-7. PubMed ID: 16705554
[TBL] [Abstract][Full Text] [Related]
10. [Noninvasive screening for pheochromocytoma in patients with an incidentally discovered adrenal mass: usefulness of provocative test with metoclopramide and 131I-metaiodobenzylguanidine scintigraphy].
Yokoyama H; Tsuji Y
Hinyokika Kiyo; 1999 Oct; 45(10):677-80. PubMed ID: 10586357
[TBL] [Abstract][Full Text] [Related]
11. Peri-adrenal hemangioma mimicking a pheochromocytoma on metaiodobenzylguanidine (MIBG) scan.
Licup NL; Zaza AA; Copeland RJ; Peiris AN
Tenn Med; 2011 Sep; 104(8):39-40, 42. PubMed ID: 21957850
[TBL] [Abstract][Full Text] [Related]
12. Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. Primary and secondary evaluation for localization of phaeochromocytomas.
Berglund AS; Hulthén UL; Manhem P; Thorsson O; Wollmer P; Törnquist C
J Intern Med; 2001 Mar; 249(3):247-51. PubMed ID: 11285044
[TBL] [Abstract][Full Text] [Related]
13. [131I-meta-iodobenzylguanidine scintigraphy in patients with a suspected pheochromocytoma. A comparison with CT and biohumoral parameters].
Maurelli L; Cuocolo A; Lastoria S; Brunetti A; Maurea S; Lembo G; Klain M; Caracò C; Salvatore M
Radiol Med; 1991 Dec; 82(6):839-43. PubMed ID: 1788441
[TBL] [Abstract][Full Text] [Related]
14. False-positive 123I-metaiodobenzylguanidine (MIBG) scan in a patient with angiomyolipoma; positive MIBG scan does not necessarily indicate the presence of pheochromocytoma.
Takasu N; Hayashi M; Takara M; Iha T; Kouki T; Ohshiro Y; Ogawa Y
Intern Med; 2007; 46(20):1717-21. PubMed ID: 17938527
[TBL] [Abstract][Full Text] [Related]
15. A meta-iodobenzylguanidine scintigraphic scoring system increases accuracy in the diagnostic management of pheochromocytoma.
Cecchin D; Lumachi F; Marzola MC; Opocher G; Scaroni C; Zucchetta P; Mantero F; Bui F
Endocr Relat Cancer; 2006 Jun; 13(2):525-33. PubMed ID: 16728579
[TBL] [Abstract][Full Text] [Related]
16. The utility of metaiodobenzylguanidine (MIBG) scintigraphy in patients with pheochromocytoma.
Greenblatt DY; Shenker Y; Chen H
Ann Surg Oncol; 2008 Mar; 15(3):900-5. PubMed ID: 18193324
[TBL] [Abstract][Full Text] [Related]
17. Detection of medullary thyroid cancer with MIBG imaging for pheochromocytoma.
Newton TD; Augustine T; Arumugam P; Malik RA
Clin Nucl Med; 2008 May; 33(5):328-9. PubMed ID: 18431145
[TBL] [Abstract][Full Text] [Related]
18. [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas.
van der Harst E; de Herder WW; Bruining HA; Bonjer HJ; de Krijger RR; Lamberts SW; van de Meiracker AH; Boomsma F; Stijnen T; Krenning EP; Bosman FT; Kwekkeboom DJ
J Clin Endocrinol Metab; 2001 Feb; 86(2):685-93. PubMed ID: 11158032
[TBL] [Abstract][Full Text] [Related]
19. False-positive diagnosis of adrenal phaeochromocytoma on metaiodobenzylguanidine (MIBG) [correction of MIGB] scan.
Houghton A; Clarke S; Jourdan M
Br J Clin Pract; 1990 Oct; 44(10):411-2. PubMed ID: 2268520
[No Abstract] [Full Text] [Related]
20. 68Ga-DOTATATE PET in neuroectodermal tumours: first experience.
Win Z; Al-Nahhas A; Towey D; Todd JF; Rubello D; Lewington V; Gishen P
Nucl Med Commun; 2007 May; 28(5):359-63. PubMed ID: 17414885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
